期刊文献+

巨噬细胞与乙型肝炎相关性肝病肝移植后乙型肝炎复发的联系 被引量:3

Relationship between macrophages and hepatitis B recurrence in hepatitis B-related patients after liver transplantation
下载PDF
导出
摘要 背景:有文献报道外周血单个核细胞存在HBV-CCCDNA,那么复发的乙型肝炎病毒是否可能来自被巨噬细胞吞噬但未完全清除的乙型肝炎病毒DNA颗粒?目的:探讨人巨噬细胞与乙型肝炎相关性肝病肝移植后乙型肝炎复发的联系。方法:采集13例因乙型肝炎致肝硬化、肝癌等终末期肝病行同种异体肝移植后乙型肝炎复发患者的抗凝静脉血,另采集14例肝移植后乙型肝炎未复发患者外周血作为对照。Ficoll密度梯度离心法分离上述标本得外周血单个核淋巴细胞,含体积分数10%小牛血清的RPMI1640培养基和重组人粒-巨噬细胞集落刺激因子体外诱导培养7d,得贴壁细胞。流式细胞技术检测细胞表面特征性标志抗体CD14以鉴定贴壁细胞性质。荧光定量PCR检测培养所得巨噬细胞乙型肝炎病毒共价、环状、闭合DNA(HBV-CCCDNA)。结果与结论:13例乙型肝炎相关性肝病肝移植后复发患者巨噬细胞内HBV-CCCDNA阳性率69.23%,14例未复发患者中发现1例阳性,阳性率7.14%,两组比较差异有显著性意义(P<0.01)。提示肝移植后乙型肝炎复发可能与其巨噬细胞中的HBV-CCCDNA有关。 BACKGROUND:HBV-CCCDNA existing in peripheral blood mononuclear cell has been reported in literatures, then, whether the recurrent hepatitis B (HBV) possibly comes from the DNA grains which are phagocytized by macrophages but not clear wholly. OBJECTIVE:To investigate the relationship between macrophages and HBV recurrence in HBV-related patients after liver transplantation. METHODS:Venous blood with anticoagulation was extracted from 13 different HBV-related patients whose hepatitis B recurred after liver transplantation, while, we collected 14 examples from patients whose HBV was negative after liver transplantation for comparison. These examples were separated though Ficoll-Hypaque density centrifugation to get PBMC, then PBMC was cultured for 7 days with rhGM-CSF and RPMI-1640 which contained 10% calf serum to get adherent cells. Special antibody CD-14 was detected with flow cytometry to assay the adherent cells nature. HBV-CCCDNA within the cells was detected though fluorescent-quantitative PCR. RESULTS AND CONCLUSION:Of 13 patients who had HBV again after liver transplantation, 69.23% were HBV-CCCDNA positive within macrophages. Only 1 patient of 14 whose HBV did not recur, and its HBV- CCCDNA was positive, that was 7.14% (P 0.01). There is probably a relationship between HBV recurrence after liver transplantation and HBV CCCDNA in macrophages.
作者 陈映 吴忠均
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第18期3235-3238,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金面上项目 编号30772055。项目名称:乙型肝炎相关性肝病肝移植术后乙肝复发机制的研究~~
  • 相关文献

参考文献4

二级参考文献14

共引文献14134

同被引文献47

  • 1陈耿,王槐志,董家鸿.肝移植术后结核病的防治[J].中华医院感染学杂志,2004,14(7):839-840. 被引量:3
  • 2吴月平,凌勇武,王世蓬,罗文明,黄松平,吴萍,刘先进.乙型肝炎相关性肝脏疾病肝移植后乙肝病毒复发的预防及检测[J].齐齐哈尔医学院学报,2007,28(9):1063-1064. 被引量:2
  • 3刘先进,黄松平,吴月平.乙型肝炎相关性肝脏疾病肝移植术后乙肝病毒复发的预防[J].胃肠病学和肝病学杂志,2007,16(4):312-313. 被引量:2
  • 4Delia DA,José IH. Prophylaxis and treatment of hepatitis B infection in the setting of liver transplantation[J].Revista Espanola de Enfermedades Digestivas,2011,(03):142-149.
  • 5Seehofer D,Berg T. Prevention of hepatitis B recurrence after liver transplantation[J].Transplantation,2005.S120-S124.
  • 6Gunther M,Neuhaus R,Bauer T. Immunization with an adjuvant hepatitis B vaccine in liver transplant recipients:antibody decline and booster vaccination with conventional vaccine[J].Liver Transplantation,2006.316-319.
  • 7Stark K,Gunther M,Schonfeld C. Immunizations in solid-organ transplant recipients[J].Lancet,2002.957-965.
  • 8Lai CL,Chien RN,Leung NW. A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group[J].New England Journal of Medicine,1998,(02):61-68.
  • 9Dienstag JL,Goldin RD,Heathcote EJ. Histological outcome during long-term lamivudine therapy[J].Gastroenterology,2003,(01):105-117.
  • 10Leung NWY,Lai CL,Chang TT. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates:results after 3 years of therapy[J].Hepatology,2001,(06):1527-1532.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部